Cargando…
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Treatment options for patients with venous thromboembolism (VTE) include warfarin and direct oral anticoagulants (DOACs). Although DOACs are easier to administer than warfarin and do not require routine laboratory monitoring, few studies have directly assessed whether patients are more satisfied wit...
Autores principales: | Fang, Margaret C., Go, Alan S., Prasad, Priya A., Hsu, Jin-Wen, Fan, Dongjie, Portugal, Cecilia, Sung, Sue Hee, Reynolds, Kristi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605968/ https://www.ncbi.nlm.nih.gov/pubmed/33834371 http://dx.doi.org/10.1007/s11239-021-02437-z |
Ejemplares similares
-
Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023) -
The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results
por: Portugal, Cecilia, et al.
Publicado: (2022) -
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study
por: Hendriks, Thomas, et al.
Publicado: (2020) -
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
por: Fang, Margaret C., et al.
Publicado: (2023) -
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
por: Lutsey, Pamela L., et al.
Publicado: (2019)